• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜液中CA - 125测量的干扰因素。

Interference in the measurement of CA-125 in peritoneal fluid.

作者信息

Williams R S, Rao C V, Yussman M A

机构信息

Department of Obstetrics and Gynecology, University of Louisville, Kentucky.

出版信息

Fertil Steril. 1988 Mar;49(3):547-50.

PMID:3422629
Abstract

CA-125 has been found to be mildly elevated in the serum of patients with advanced stages of endometriosis, but not with minimal endometriosis. Peritoneal fluid levels were measured in conjunction with serum levels in 12 consecutive patients with endometriosis and 12 consecutive normal controls. Apparent peritoneal fluid values were found to be 10-fold higher than serum levels, with no difference between the study groups (130 versus 106 U/ml, respectively). However, when peritoneal fluid was diluted to validate the assay system in peritoneal fluid, no sample of peritoneal fluid showed decreased binding with serial dilutions of 1:2, 1:5, and 1:10. At a dilution of 1:100, there was some decreased binding, but the level was 17-fold higher than expected. The source of this interference is unknown.

摘要

研究发现,在晚期子宫内膜异位症患者的血清中,CA - 125会轻度升高,但在轻度子宫内膜异位症患者中则不会。对12例连续的子宫内膜异位症患者和12例连续的正常对照者同时检测了血清和腹腔液中的CA - 125水平。结果发现,腹腔液中的CA - 125水平明显高于血清水平,约为血清水平的10倍,且研究组之间无差异(分别为130 U/ml和106 U/ml)。然而,当对腹腔液进行稀释以验证检测系统时,在1:2、1:5和1:10的系列稀释中,没有一份腹腔液样本显示结合力下降。在1:100的稀释度下,结合力有一定程度的下降,但仍比预期高17倍。这种干扰的来源尚不清楚。

相似文献

1
Interference in the measurement of CA-125 in peritoneal fluid.腹膜液中CA - 125测量的干扰因素。
Fertil Steril. 1988 Mar;49(3):547-50.
2
Serum and peritoneal fluid CA-125 levels in early stage endometriosis.早期子宫内膜异位症患者血清和腹腔液中CA-125水平
Gynecol Obstet Invest. 1990;30(2):105-8. doi: 10.1159/000293228.
3
Serum and peritoneal fluid CA-125 levels in patients with endometriosis.子宫内膜异位症患者的血清和腹腔液CA-125水平
Fertil Steril. 1994 Mar;61(3):438-42. doi: 10.1016/s0015-0282(16)56572-8.
4
Multiple serum marker assay in the diagnosis of endometriosis.
Gynecol Endocrinol. 1992 Dec;6(4):265-9. doi: 10.3109/09513599209024989.
5
Serum and peritoneal lavage fluid CA-125 levels in endometriosis.子宫内膜异位症患者血清及腹腔灌洗液中CA - 125水平
Fertil Steril. 1988 Sep;50(3):430-3. doi: 10.1016/s0015-0282(16)60127-9.
6
CA 125 in serum, peritoneal fluid, active lesions, and endometrium of patients with endometriosis.子宫内膜异位症患者血清、腹腔液、活性病灶及子宫内膜中的CA 125
Am J Obstet Gynecol. 1988 Jan;158(1):166-70. doi: 10.1016/0002-9378(88)90803-4.
7
CA 125 in peritoneal fluid and serum of patients with endometriosis.子宫内膜异位症患者腹腔液和血清中的CA 125
Eur J Obstet Gynecol Reprod Biol. 1988 Oct;29(2):153-8. doi: 10.1016/0028-2243(88)90142-6.
8
CA 125 in peritoneal fluid from patients with endometriosis.子宫内膜异位症患者腹腔液中的CA 125
Hum Reprod. 1991 Nov;6(10):1400-3. doi: 10.1093/oxfordjournals.humrep.a137277.
9
[Serum and peritoneal fluid CA-125 concentration in women with endometriosis].[子宫内膜异位症女性的血清和腹腔液CA-125浓度]
Ginekol Pol. 2001 Dec;72(12A):1365-9.
10
Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis.盆腔子宫内膜异位症女性血清与腹腔液中CA - 125水平的正相关性。
Sao Paulo Med J. 2006 Jul 6;124(4):223-7. doi: 10.1590/s1516-31802006000400010.

引用本文的文献

1
Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis.盆腔子宫内膜异位症女性血清与腹腔液中CA - 125水平的正相关性。
Sao Paulo Med J. 2006 Jul 6;124(4):223-7. doi: 10.1590/s1516-31802006000400010.
2
Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies.在诱导妊娠的黄体期及最初12周期间出现的CA125升高现象中,卵巢因素的参与因药物诱导多个卵泡发育(MFD)而被放大。
J Assist Reprod Genet. 1995 Apr;12(4):263-8. doi: 10.1007/BF02212929.